Automated Inventory Management Saves Time, Helps Patients

Q: What role does Mexico play in BD's global operations?

A: Mexico remains a critical region for us, as it was the first country outside of the United States where the company invested. We operate 12 manufacturing plants in Mexico, employing over 17,000 people. As a company committed to advancing global health, we recognize the challenges and opportunities within the Mexican market. Our goal is to position our leading technologies in the research, laboratory, and medical markets, specifically targeting hospitals and disease treatment. Our portfolio in Mexico reflects these priorities. BD is dedicated to advancing disease detection and treatment through automation and intelligent processes, aiming to achieve more with fewer resources. Our strategies align with our portfolio and ongoing investments, offering comprehensive solutions for diagnosing and monitoring certain types of cancer, pharmaceutical automation, and laboratory automation, among other areas.

Q: What are Mexico's main health concerns, and how does BD assist in addressing them?

A: At BD, we believe that the convergence of healthcare and technology presents a significant opportunity to improve patient and population health. We focus on developing innovative solutions that transform healthcare processes, aiming to eliminate medical and medication supply errors. Simultaneously, we invest in innovations to diagnose and monitor patients with chronic diseases such as cervical and breast cancer, leukemia, and HIV, among others.

Q: Why does BD's prioritize technological innovation?

A: BD is a company with a strong foundation in innovation, continuously investing in technology development, services, and patient care solutions. Our technologies enable healthcare providers to obtain rapid and accurate test results, leading to expedited diagnoses and treatments essential for patient care. We also offer interventional products, like biopsy needles that aid in cancer diagnosis. Our efforts particularly focus on cancer due to its significant impact on healthcare systems, though we recognize the importance of addressing other diseases. For example, we are advancing HPV diagnostics and offer laboratory tests that provide higher accuracy compared to other methods. Additionally, we provide solutions for automating hospital pharmacy inventory management.

Q: How does automation improve hospital inventory management?

A: Hospitals heavily rely on manual processes, which can be inefficient and prone to errors. Nursing staff often spend significant time on paperwork and inventory management, diverting their attention from patient care. Our automation solutions aim to ensure precise inventory management by delivering the right medication to the right place at the right time. For example, our BD Pyxis system can be deployed throughout hospital floors, interfacing with central systems to provide real-time inventory information. This allows hospitals to efficiently manage medication supplies based on demand, reducing errors and ensuring timely medication delivery.

Moreover, by automating inventory recording and control, hospitals can generate accurate inventory reports with a single click, eliminating the need for manual counting. This automation reduces the need for excessive inventory, saving costs and improving overall efficiency. Hospitals often stockpile inventory as a precaution due to uncertainties in manual inventory management, leading to financial strain. Our solutions help mitigate these issues by providing precise inventory control, reducing costs for hospitals and healthcare systems.

Q: Does this solution only work for hospitals or also for retail pharmacies?

A: At BD, we have a dedicated solution for retail settings called BD Rowa, which focuses on automating medication storage and dispensing. These robots optimize pharmacy processes, from inventory placement and management to medication dispensing. They maximize efficiency in inventory management and simplify stock control, reducing staff involvement in administrative tasks and allowing more time for patient care. Operating with a mechanical arm that organizes products inside the robot, BD Rowa maximizes effective storage capacity and optimizes space usage. Implementing BD Rowa can reduce the time spent on shelf placement by up to 28% and the time spent searching for products by up to 33%. It also frees up space for product display and increases sales.

Q: What are BD's priorities and objectives in Mexico for 2024?

A: BD is exploring avenues to revolutionize our business approach, aiming to enhance not only our capabilities but also those of the entire healthcare system. We are engaging in dialogue with government entities, as well as public and private hospitals, showcasing our innovative technologies. Our aspiration is to contribute to the advancement of Mexico's healthcare system, promoting business growth while introducing new technologies to the market. We are continuously collaborating with other companies through B2B partnerships and agreements. Recognizing that progress requires collective effort, BD is committed to driving advancements in healthcare.

BD is one of the largest medical technology companies in the world. It is advancing healthcare by improving medical discovery, diagnostics, and the delivery of care